Robert de Luccia

Robert de Luccia

Fortune : 73 011 $ au 31/07/2026

80 ans
Health Technology
Consumer Durables
Consumer Services

Profil

Mr. Robert J.
de Luccia
is an Executive Chairman at Acurx Pharmaceuticals, Inc. and a Lead Independent Director at IBEX Technologies, Inc. He is on the Board of Directors at PLx Pharma, Inc. and IBEX Technologies, Inc. Mr. de Luccia was previously employed as an Executive Chairman by Dipexium Pharmaceuticals, Inc., a Chairman, President & Chief Executive Officer by MacroChem Corp., a President & Chief Executive Officer by Immunomedics, Inc., a Chief Executive Officer by Morris Plains Property LLC, a Vice President-Marketing & Sales Operations by Pfizer Inc., a President by Sanofi Winthrop, a President by Sanofi-Aventis U.S.
LLC, and a President by Sterling Winthrop, Inc. He also served on the board at Topigen Pharmaceuticals, Inc. He received his undergraduate degree from Iona College and an MBA from Iona College.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
20/04/2026 50 702 ( 3,2 % ) 73 011 $ 31/07/2026

Postes actifs de Robert de Luccia

SociétésPosteDébut
IBEX TECHNOLOGIES Directeur/Membre du Conseil 01/01/2000
ACURX PHARMACEUTICALS, INC. Fondateur 01/07/2017
PLX PHARMA WINDDOWN CORP. Directeur/Membre du Conseil 01/04/2017

Anciens postes connus de Robert de Luccia

SociétésPosteFin
Fondateur 01/04/2017
Directeur Général 01/01/2009
IMMUNOMEDICS, INC. Directeur Général 01/01/1999
President -
Directeur Général -
Voir l'expérience en détail de Robert de Luccia

Formation de Robert de Luccia

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

48

Relations au 1er degré

13

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées13

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Durables

Consumer Services

Health Technology

Health Technology

Finance

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Robert de Luccia
🔇